ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury

Sui, Xiaolu; Xie, Tingfei; Xu, Yunpeng; Zhang, Aisha; Zhang, Yanzi; Gu, Fengjuan; Li, Lixiang; Xu, Zibin; Chen, Jihong*南方医科大学
Mediators of Inflammation2023-7-13DOI: 10.1155/2023/5007488
9阅读
引用收藏
分享

摘要

Interstitial inflammation is an important mechanism of pathological damage in renal injury caused by hyperuricemia. Protease-activated receptor-2 (PAR2) is a class of targets that act upstream of the PI3K/AKT/NF-& kappa;B pathway and is involved in various inflammatory diseases. We induced a hyperuricemia model in rats by adenine and ethambutol gavage in an in vivo experiment. We demonstrated that PAR2 and PI3K/AKT/NF-& kappa;B pathway expression were significantly upregulated in renal tissues, with massive inflammatory cell infiltration in the renal interstitium and renal tissue injury. Treating hyperuricemic rats with AZ3451, a selective metabotropic antagonist of PAR2, we demonstrated that PAR2 antagonism inhibited the PI3K/AKT/NF-& kappa;B pathway and attenuated tubular dilation and tubulointerstitial inflammatory cell infiltration. The phospholipid metabolism profiles provided a perfect separation between the normal and hyperuricemic rats. In addition, we also found that AZ3451 can affect phospholipid metabolism. Our work suggests that PAR2 may mediate hyperuricemia-mediated renal injury by activating the PI3K/AKT/NF-& kappa;B pathway. The PAR2 antagonist AZ3451 may be a promising therapeutic strategy for hyperuricemia-induced inflammatory responses.

学科与关键词

关键词
COAGULATION PROTEASESSIGNALING PATHWAYTRANSPORTERSINFLAMMATIONMODULATIONROLESCELLS
相关
加载中…
  • Fufang Zhenzhu Tiaozhi capsule ameliorates hyperuricemic nephropathy by inhibition of PI3K/AKT/NF-?B pathway
    Li, Ming -Hui; Guan, Jin; Chen, Zhe; Mo, Ju-Xian; Wu, Kai-Reng; Hu, Xu-Guang; Lan, Tian*; Guo, JiaoJournal of Ethnopharmacology, 2022, 298: 115644.被引 8
  • Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway
    Liu, Yanlu; Gong, Shiting; Li, Kejian; Wu, Gong; Zheng, Xiaohong; Zheng, Jingna; Lu, Xiaowei; Zhang, Luyao; Li, Jincan; Su, Ziren; Liu, Yuhong; Xie, Jianhui; Chen, Jiannan*; Li, Yucui*Biomedicine and Pharmacotherapy, 2022, 156: 113941.被引 12
  • Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo
    Xu, Guitao; Wu, Lele; Yang, Hongxuan; Liu, Tianfeng; Tong, Ying; Wan, Jiliang; Han, Bin; Zhou, Lin*; Hu, Xuguang*Food and Chemical Toxicology, 2024, 183: 114307.
查看全部 →

发表信息

论文状态
公开发表
期刊
Mediators of Inflammation
发表日期
2023-07-13
卷期
第 2023 卷
页码
5007488
DOI
10.1155/2023/5007488
语言
ENGLISH
成果收录
SCIE
资助标注
Science and Technology Planning Project of Shenzhen Municipality [JCYJ20180305123730301, JCYJ20160427191440905]

作者

  • S

    Sui, Xiaolu (第一作者)

    2 · shenzhen univ

  • X

    Xie, Tingfei

    2 · southern med univ

查看全部 9 位作者收起作者
  • X

    Xu, Yunpeng

    2 · shenzhen univ

  • Z

    Zhang, Aisha

    2 · shenzhen univ

  • Z

    Zhang, Yanzi

    2 · shenzhen univ

  • G

    Gu, Fengjuan

    2

  • L

    Li, Lixiang

    2 · shenzhen univ

  • X

    Xu, Zibin

    2 · southern med univ

  • C

    Chen, Jihong (通讯)

    2 · southern med univ · shenzhen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417